| Title | Date | PubMed ID |
|---|
| Characterisation of de novo mutations in the C-terminal domain of proprotein convertase subtilisin/kexin type 9. | 2015 May | 25744035 |
| Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9). | 2015 Mar | 25600226 |
| The proprotein convertase subtilisin/kexin type 9 (PCSK9) active site and cleavage sequence differentially regulate protein secretion from proteolysis. | 2014 Oct 17 | 25210046 |
| Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins. | 2014 May | 24680982 |
| Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1). | 2013 | 23675525 |
| Furin-cleaved proprotein convertase subtilisin/kexin type 9 (PCSK9) is active and modulates low density lipoprotein receptor and serum cholesterol levels. | 2012 Dec 21 | 23135270 |
| Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor. | 2012 Jul | 22580899 |
| Novel domain interaction regulates secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein. | 2011 Dec 16 | 22027821 |
| N-glycosylation controls trafficking, zymogen activation and substrate processing of proprotein convertases PC1/3 and subtilisin kexin isozyme-1. | 2011 Oct | 21527438 |
| Affinity and kinetics of proprotein convertase subtilisin/kexin type 9 binding to low-density lipoprotein receptors on HepG2 cells. | 2011 Aug | 21692990 |